Kazia Therapeutics Limited
KZIA
$6.75
$0.172.58%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -79.86% | -51.58% | -27.77% | 10.96% | 40.88% |
| Total Depreciation and Amortization | -0.75% | -0.96% | -2.60% | -3.94% | -4.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 516.38% | 569.97% | 674.39% | 468.61% | -2,435.70% |
| Change in Net Operating Assets | 193.72% | 153.22% | 125.73% | 61.28% | -19.96% |
| Cash from Operations | 8.63% | 24.17% | 38.46% | 39.65% | 40.17% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -100.08% | -0.15% | -- | -- | -- |
| Total Debt Repaid | 100.22% | 0.43% | -- | -- | -- |
| Issuance of Common Stock | -9.54% | -33.56% | -55.46% | -22.53% | 21.26% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 92.27% | 61.48% | 6.04% | -22.90% | -46.43% |
| Cash from Financing | -8.45% | -32.19% | -55.18% | -23.37% | 20.06% |
| Foreign Exchange rate Adjustments | 1,473.40% | 307.06% | -80.88% | -100.38% | -102.17% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 37.79% | -39.76% | -65.82% | 68.02% | 93.16% |